ISPOR - Modeling the Impact on Clinical Utility, Patient Harms, And Cost of Biomarkers for the Management of Incidentally Detected Pulmonary Nodules

Full Text

Modeling the Impact on Clinical Utility, Patient Harms, And Cost of Biomarkers for the Management of Incidentally Detected Pulmonary Nodules

Abstract

Authors

SS Soneji GA Silvestri NT Tanner A Piscitello H Rinde

Back to Volume 21, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now